LifeMD, Inc. (LFMD)

Sentiment-Signal

24,9
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Unternehmen & Branche

NameLifeMD, Inc.
TickerLFMD
CIK0000948320
BoerseUS
SektorHealthcare
IndustrieMedical - Pharmaceuticals
SIC8011 · Services-Offices & Clinics of Doctors of Medicine

Wertpapier & Kennzahlen

CUSIP
ISIN
TypCommon Stock
Marktkapitalisierung211,1 Mio. USD
Beta1,77
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K194,055,19814,354,1060.2570,411,31923,156,580
2025-09-3010-Q60,172,470-3,806,11765,983,3781,314,334
2025-06-3010-Q62,673,395-1,619,664-0.0573,564,702-1,782,554
2025-03-3110-Q64,129,174-183,778-0.0273,614,333-2,328,732
2024-12-3110-K154,824,075-21,409,016-0.6076,096,297-9,083,214
2024-12-3110-Q208,839,282-21,409,016-0.6076,096,297-9,083,214
2024-09-3010-Q53,272,294-4,657,922-0.1372,559,922-7,720,122
2024-06-3010-Q50,661,845-6,875,64063,820,489-4,206,329
2024-03-3110-Q44,144,264-6,768,35561,455,274-845,303
2023-12-3110-K152,547,006-20,595,99258,480,7093,505,372
2023-09-3010-Q38,613,911-6,122,43540,691,024-12,671,164
2023-06-3010-Q35,946,913-6,733,00035,446,389-16,021,557
2023-03-3110-Q33,126,335-4,008,45633,869,830-12,007,521
2022-12-3110-K119,033,520-45,535,65925,665,853-11,395,777
2022-09-3010-Q31,412,469-7,281,67333,361,561-568,480
2022-06-3010-Q30,458,498-13,018,96237,969,4813,510,958
2022-03-3110-Q29,042,837-13,299,67525,665,85313,175,076
2021-12-3110-K92,875,806-60,897,70449,923,24322,740,033
2021-09-3010-Q24,947,199-14,353,37516,351,645-17,557,940
2021-06-3010-Q22,313,611-16,830,70023,987,500-7,031,472

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×